Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mercola

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Oncogene|November 21, 1996
Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell linesA Calogero, L Cuomo, M D'Onofrio, et al.
Human Gene Therapy|February 1, 1995
Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I studyR E Sobol, I Royston, H Fakhrai, et al.
In Vitro Cellular & Developmental Biology. Animal|March 1, 1995
Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathwayR A Gjerset, H Fakhrai, D L Shawler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomasA Calogero, A Arcella, G De Gregorio, et al.
Molecular and Cellular Biology|July 22, 1998
Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell linesY Li, B Lin, A Agadir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I studyR E Sobol, D L Shawler, C Carson, et al.
Leukemia|May 3, 2002
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferationL D Cripe, V M Gelfanov, E A Smith, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Oncogene|November 21, 1996
Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell linesA Calogero, L Cuomo, M D'Onofrio, et al.
Human Gene Therapy|February 1, 1995
Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I studyR E Sobol, I Royston, H Fakhrai, et al.
In Vitro Cellular & Developmental Biology. Animal|March 1, 1995
Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathwayR A Gjerset, H Fakhrai, D L Shawler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomasA Calogero, A Arcella, G De Gregorio, et al.
Molecular and Cellular Biology|July 22, 1998
Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell linesY Li, B Lin, A Agadir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I studyR E Sobol, D L Shawler, C Carson, et al.
Leukemia|May 3, 2002
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferationL D Cripe, V M Gelfanov, E A Smith, et al.
Pageof 6